Phase 1 Study of Anito-cel, a d-Domain BCMA CAR T Cell for Refractory or Recurrent Myeloma
New England Journal of Medicine, Volume 395, Issue 12, Page 1180-1192, September 24, 2026.
We haven't written up this one. NEJM has the full story — the link below goes straight to it.